Stephen Cahill, DO
Dermatology · Grand Rapids, MINPI 1467650325
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,502 of the $15,377 with a category attached, or 61.8%. 34 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 39.9% of the total. Reporting peaked in 2024 at $7,935 and has fallen 74.7% since, to $2,008 in 2025.
Across 338 payments — averaging $45.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$6K
- AbbVie$2K
- Sanofi$1K
- Amgen$907
- Johnson & Johnson$809
- Incyte Corporation$726
- plus $4K from 28 others
What the payments were for
- Consulting fees$5,42535%
- Food & beverage$9,50262%
- Education$4503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 30 | $6,137 |
| AbbVie | 75 | $1,919 |
| Sanofi | 40 | $1,205 |
| Amgen | 26 | $907 |
| Johnson & Johnson | 38 | $809 |
| Incyte Corporation | 18 | $726 |
| UCB, Inc. | 13 | $445 |
| Regeneron Healthcare Solutions, Inc. | 12 | $341 |
| Arcutis Biotherapeutics, Inc. | 10 | $310 |
| Novartis | 3 | $272 |
| Sanofi-aventis U.S. LLC | 3 | $261 |
| Galderma Laboratories, L.p. | 6 | $238 |
| Pfizer | 12 | $231 |
| Journey Medical Corporation | 4 | $229 |
| Bristol Myers Squibb | 7 | $194 |
| Lilly USA, LLC | 7 | $158 |
| Sun Pharmaceutical Industries Inc. | 3 | $155 |
| Biofrontera Inc. | 2 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Boehringer Ingelheim | 2 | $94 |
| Dermavant Sciences, Inc. | 6 | $87 |
| Dermira, Inc. | 3 | $67 |
| Kerecis Limited | 2 | $41 |
| LEO Pharma Inc. | 2 | $40 |
| Organon | 2 | $39 |
| Almirall LLC | 1 | $37 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $28 |
| Convatec Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,377 in reported general payments places this provider in the 85th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 22 | $436,097 |
| Dupixent PenDupilumab | 31 | $112,915 |
| Humira(Cf) PenAdalimumab | 15 | $98,922 |
| Yuflyma(Cf) Autoinject (2 Pck)Adalimumab-Aaty | 12 | $80,514 |
| Fluorouracil | 130 | $7,296 |
| Clobetasol Propionate | 171 | $7,230 |
| Tretinoin | 66 | $6,638 |
| Fluocinonide | 129 | $4,343 |
| Ketoconazole | 207 | $3,957 |
| Calcipotriene | 24 | $3,200 |
| Metronidazole | 52 | $2,693 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 178 | $2,661 |
| Tacrolimus | 20 | $2,227 |
| Triamcinolone Acetonide | 179 | $1,535 |
| Clindamycin Phosphate | 60 | $1,256 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Grand Rapids
- Kurt AshackGrand Rapids$199K
- David OberlinGrand Rapids$103K
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Steven DaveluyDearborn$350K
- Benjamin WorkmanMidland$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.